Alberta Investment Management Corp (AIMCo)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,332	Closed	-$974K	–	987
2016 Q4	$974K	Buy	30,332 +530	+2%	+$22.6K	0.01%	540
2016 Q3	$1.49M	Buy	29,802 +260	+0.9%	+$10.8K	0.01%	485
2016 Q2	$1.25M	Hold	29,542	–	–	0.01%	483
2016 Q1	$1.95M	Sell	29,542 -63,967	-68%	-$3.34M	0.03%	385
2015 Q4	$5.81M	Sell	93,509 -4,368	-4%	-$307K	0.07%	318
2015 Q3	$6.55M	Hold	97,877	–	–	0.08%	296
2015 Q2	$9.52M	Buy	97,877 +67,376	+221%	+$6.41M	0.1%	260
2015 Q1	$2.85M	Buy	+30,501	New	+$2.6M	0.03%	425

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s MACK Position: Q1 2017 in Review

Alberta Investment Management Corp (AIMCo) sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2017, closing a stake of 30,332 shares — an estimated $974K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MACK in Q1 2015 and held it in 8 quarters. The position peaked at $9.52M in Q2 2015. 116 funds tracked by Wall St. Rank hold MACK as of Q1 2017.

Alberta Investment Management Corp (AIMCo) reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 30,332 Merrimack Pharmaceuticals, Inc. shares in Q1 2017, an estimated $974K.
Alberta Investment Management Corp (AIMCo) first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2015 and held it in 8 quarters.
Alberta Investment Management Corp (AIMCo)'s Merrimack Pharmaceuticals, Inc. position peaked at $9.52M in Q2 2015.
116 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2017.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2017, filed 15 May 2017.